ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (Serenity)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00840190
Recruitment Status : Completed
First Posted : February 10, 2009
Last Update Posted : November 21, 2012
Sponsor:
Information provided by (Responsible Party):
Piramal Enterprises Limited

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : September 2011